Discrete CTO

• Research type

  Research Study

• Full title

  DISseCtion RE-enTry Evaluation with Absorb Bioresorbable Vascular Scaffolds in Chronic Total Occlusion.\nThe DISCRETE-CTO Study

• IRAS ID

  192579

• Contact name

  Simon J Walsh

• Contact email

  simon.walsh@belfasttrust.hscni.net

• Sponsor organisation

  Belfast Health and Social Care Trust

• Clinicaltrials.gov Identifier

  NCT02936011

• Duration of Study in the UK

  2 years, 6 months, 1 days

• Research summary

  This is a single arm observational registry that aims to describe outcomes for patients who have chronic total occlusions (CTOs) of coronary arteries who are treated using modern techniques and completely absorbable stents. Historically, stents that have been implanted in coronary arteries for narrowing or complete blockages have been made from metal. This study will examine the commercially available and CE marked Absorb Bioresorbable Vascular Scaffold (BVS) when it is implanted to treat a coronary CTO.

• REC name

  HSC REC B

• REC reference

  16/NI/0011

• Date of REC Opinion

  15 Feb 2016

• REC opinion

  Favourable Opinion